Kristen Ricchetti-masterson PhD, MSPH

Dr. Kristen Ricchetti-Masterson is the Senior Director of Real World Evidence (RWE) at Sarepta Therapeutics where she leads real-world scientific initiatives supporting gene therapies for patients with Duchenne Muscular Dystrophy. This role includes leading observational studies (both primary and secondary data) as well as the integration of RWE across the drug development lifecycle through contributions to clinical development and regulatory engagement, post-marketing activities, and global market access. She has a decade of pharmaceutical industry experience in pharmacoepidemiology and RWE roles in dermatology, immunoinflammatory, and neurology therapy areas. Dr. Ricchetti-Masterson earned her Ph.D. and M.S.P.H. in Epidemiology from The University of North Carolina at Chapel Hill.